24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Molecular and biochemical basis <strong>of</strong> disease<br />

ted as autosomal dominant and recessive, X-linked, or mitochondrial<br />

traits . Mitochondrial DNA (mtDNA) defects are found in an increasing<br />

number <strong>of</strong> cases <strong>of</strong> DCM. We identified a novel heteroplasmic<br />

mitochondrial DNA (m .4322dupC) mutation in tRNA Ile gene associated<br />

with isolated dilated cardiomyopathy (DCM) as maternal trait .<br />

Mutation screening techniques and automated DNA sequencing were<br />

performed to identify mtDNA mutations and to assess heteroplasmy<br />

in family’s proband and healthy control subjects . All family members<br />

tested had heteroplasmic mtDNA (m .4322dupC) mutation . We also<br />

screened 350 normal controls for this mutation and found no evidence<br />

<strong>of</strong> heteroplasmy .<br />

The m .4322dupC mutation was found in the skeletal tissue from the<br />

proband that exhibited slightly reduced deficiency <strong>of</strong> mitochondrial respiratory<br />

chain enzymes (complex III) . The present study reports the<br />

novel m .4322dupC mutation in tRNA Ile gene, which is possibly associated<br />

to the disease, to isolated DCM . It was localized in a hot-spot<br />

region for mutations and is possibly pathogenic because <strong>of</strong> a cosegregation<br />

with the matrilineal transmission <strong>of</strong> DCM .<br />

P05.067<br />

Analysis <strong>of</strong> the 12srRNA and tRNAser(UcN) genes (mtDNA) in<br />

patients with nonsyndromic hearing loss from different Russia<br />

regions<br />

L. U. Dzhemileva 1 , A. M. Tazetdinov 1 , O. L. Posukh 2 , K. A. Barashkov 3 , E. K.<br />

Khusnutdinova 1 ;<br />

1 Institute <strong>of</strong> biochemistry and genetics, Ufa, Russian Federation, 2 Institute <strong>of</strong><br />

Cytology and <strong>Genetics</strong>, Siberian Branch <strong>of</strong> Russian Academy <strong>of</strong> Sciences,<br />

Novosibirsk, Russian Federation, 3 Yakutsk Research Centre, Siberian Branch<br />

<strong>of</strong> Russian Academy <strong>of</strong> Medical Sciences, Yakutsk, Russian Federation.<br />

Hearing loss is common congenital disorder and more than 50% <strong>of</strong><br />

deafness has a genetic cause . The m .1555G>A (12SrRNA) was confirmed<br />

as the main cause <strong>of</strong> aminoglycoside induced deafness in different<br />

populations . Families with maternally inherited sensorineural<br />

hearing loss are also described in association with A7445G, T7511C,<br />

and 7472insC mutations in the tRNASer(UCN) gene . We report here<br />

the results <strong>of</strong> mutational screening for 12S rRNA and tRNASer(UCN)<br />

genes among Cx26- and Cx30-negative deaf individuals <strong>of</strong> different<br />

ethnicity from different regions <strong>of</strong> Russia . Previously, 301 unrelated<br />

patients from Volga-Ural region, 78 unrelated patients from the Republic<br />

Sakha (Yakutia, northeastern Siberia), and 119 deaf patients<br />

(75 unrelated families) from the Republic Altai (south Siberia) were<br />

analyzed for Cx26 and Cx30 mutations . Different variations at the 961<br />

position in 12S rRNA gene have been found among deaf individuals<br />

from Volga-Ural region . Five patients <strong>of</strong> different ethnicity (Russian, Tatar,<br />

Latvinian) with m .961insC, two Tatars with m .del961TinsC n , three<br />

Russian patients with m .961T>G (one from Volga-Ural region and two<br />

from Altai), and one Russian with m .961T>A, were detected . Also, the<br />

m .7444G>A (tRNASer(UCN)) was found in one Russian patient with<br />

NSHL . . Finally, m .7445G>C (tRNASer(UCN)) was found in two sibs<br />

<strong>of</strong> one Kazakh family (Altai region) in whom moderate sensorineural<br />

hearing loss was co-existed with goiter . Further studies are needed to<br />

confirm pathogenicity <strong>of</strong> some mtDNA variations associated with deafness<br />

in patients from some regions <strong>of</strong> Russia .<br />

P05.068<br />

Prevalence <strong>of</strong> the GJB2 mutations in iranian patients with<br />

deafness<br />

M. Hamid1 , M. T. Akbari2 ;<br />

1 2 Pasteur Institute <strong>of</strong> Iran, Tehran, Islamic Republic <strong>of</strong> Iran, Tarbiat Modaras<br />

University, Tehran, Islamic Republic <strong>of</strong> Iran.<br />

The commonest form <strong>of</strong> non-syndromic recessive deafness is caused<br />

by mutation in GJB2, encoding gap junction beta 2 protein on chromosome<br />

location 13q11 . It is known as DFNB1 responsible for half <strong>of</strong><br />

autosomal recessive non-syndromic deafness . The most frequent mutation<br />

35delG accounts for about 60-80% <strong>of</strong> mutations in white people<br />

<strong>of</strong> <strong>European</strong> .<br />

In this study, we report the frequency <strong>of</strong> the GJB2 gene mutations in<br />

31 unrelated Iranian families from 48 subjects affected by hereditary<br />

hearing loss (HHL) .<br />

Eight different mutations were detected in 12 families (38 .7%) by using<br />

direct-sequencing technique in coding region <strong>of</strong> GJB2 gene . Cx26<br />

related deafness mutations (35delG, R127H, V27I+E114G, Y155X,<br />

M163V and a novel 355-356 delGA) were identified in 9(29%) families<br />

in heterozygous form, 3(9 .67%) (35delG/35delG and R143W/ R143W)<br />

and 1 (3 .2%) (R32H+35delG) were homozygous and compound heterozygous<br />

respectively .<br />

Two polymorphisms V153I and (F154F +F146F) also were detected<br />

in four families and a polymorphism S86T was identified in all cases.<br />

In this population study, our data showed that the rate <strong>of</strong> GJB2 mutations<br />

is high in heterozygous form so other loci and genes related to<br />

deafness must be investigated . Moreover, the most frequent mutation<br />

was 35delG because 9 out <strong>of</strong> 18(50%) mutant alleles had this mutation<br />

.This is lower than that reported in western populations<br />

P05.069<br />

Hereditary congenital Hearing Loss: molecular analysis <strong>of</strong><br />

connexins 26, 30 and A1555G mitochondrial Point mutation in<br />

italian population<br />

L. Trotta 1 , P. Castorina 1 , F. Sironi 1 , U. Ambrosetti 1 , A. Cesarani 1 , L. Garavelli 2 ,<br />

P. Formigoni 2 , A. Murri 3 , D. Cuda 3 , D. A. Coviello 1 , P. Primignani 1 ;<br />

1 Fondazione IRCCS, Ospedale Maggiore Policlinico, Mangiagalli e Regina<br />

Elena, Milan, Italy, 2 Arcispedale S. Maria Nuova, Reggio Emilia, Italy, 3 Ospedale<br />

Guglielmo da Saliceto, Piacenza, Italy.<br />

Mutations in GJB2, encoding the gap-junction protein Connexin26,<br />

are the most common cause <strong>of</strong> non-syndromic hearing loss (NSHL)<br />

and account for about 32% <strong>of</strong> cases in the Caucasian population . We<br />

analyzed 852 patients and identified mutations in 527/1662 chromosomes<br />

. We characterised 40 different mutations and 6 polymorphisms<br />

in 299 NSHL patients . More than 100 different mutations are described<br />

but one is particularly common, the 35delG, accounting for about<br />

68% <strong>of</strong> all the Cx26 alleles we identified. The GJB6 gene deletion,<br />

del(GJB6-D13S1830), which can cause hearing loss in combination<br />

with GJB2 mutations in trans, has been found in 3 <strong>of</strong> our patients, while<br />

the del(GJB6-D13S1854) was not present in our patients’ population .<br />

Our results show that GJB2/GJB6 genes account for less than 30% <strong>of</strong><br />

NSHL in the screened cohort <strong>of</strong> patients and confirm that the 35delG<br />

mutation is the most frequent one . Moreover, 27 affected subjects<br />

were compound heterozygous for recessive GJB2 allele not including<br />

35delG and 8 were carrying dominant mutations (T55N, P58A, D179N<br />

and R184Q), indicating that the complete sequence <strong>of</strong> the gene is<br />

needed for an appropriate molecular diagnosis . The analysis <strong>of</strong> the<br />

deafness-causing A1555G substitution in MTRNR1 mitochondrial<br />

gene was carried out in patients with one or without Cx26 recessive<br />

mutations . We found 21 affected subjects carrying the A1555G and the<br />

subsequently family analysis performed in each case has led to the<br />

pre-symptomatic identification <strong>of</strong> this mutation in relatives.<br />

P05.070<br />

GJB2 analysis in Portuguese cochlear implant users<br />

J. Chora 1 , T. Matos 1 , S. Andrade 2 , J. Humberto 2 , M. Alves 2 , L. Silva 2 , C. Ribeiro<br />

2 , G. Fialho 1 , H. Caria 1,3 ;<br />

1 Center <strong>of</strong> <strong>Genetics</strong> and Molecular Biology, University <strong>of</strong> Lisbon, Lisbon, Portugal,<br />

2 ORL Department - Centro Hospitalar de Coimbra, Coimbra, Portugal,<br />

3 Higher College <strong>of</strong> Health, Polytechnic Institute <strong>of</strong> Setúbal, Setúbal, Portugal.<br />

Hearing impairment affects approximately 1 in 1000 newborns and at<br />

least 60% <strong>of</strong> these cases have a genetic origin . Despite large genetic<br />

heterogeneity, mutations in a single gene - GJB2 - are the most frequent<br />

genetic cause <strong>of</strong> severe to pr<strong>of</strong>ound pre-lingual recessive deafness<br />

in many populations . Therefore, GJB2 became the most important<br />

gene in the understanding <strong>of</strong> deafness . Hearing loss is a condition<br />

that interferes with the development <strong>of</strong> the child at a cognitive and language<br />

level . Therefore early diagnosis <strong>of</strong> deafness is important for earlier<br />

rehabilitation, namely through the use <strong>of</strong> cochlear implants . These<br />

devices replace the cochlea in a physiological context . Some studies<br />

suggest a correlation between the GJB2 genotype <strong>of</strong> the implanted<br />

individual and a phenotype that allows the success <strong>of</strong> rehabilitation<br />

due to cochlear implant<br />

The aim <strong>of</strong> our study is to analyse the GJB2 gene in a sample <strong>of</strong> 100<br />

Portuguese cochlear implant recipients . All individuals, presenting<br />

non-syndromic sensorineural severe to pr<strong>of</strong>ound bilateral recessive<br />

deafness prior implantation, were implanted in the Centro Hospitalar<br />

de Coimbra . Screening <strong>of</strong> GJB2 gene was performed by PCR and sequencing<br />

in <strong>of</strong> the entire coding region . The results obtained may represent<br />

a valuable indicator when counselling candidates for cochlear<br />

implantation .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!